يعرض 1 - 20 نتائج من 164 نتيجة بحث عن '"Martin-Liberal, Juan"', وقت الاستعلام: 0.55s تنقيح النتائج
  1. 1
    Dissertation/ Thesis

    المؤلفون: Martín Liberal, Juan Jesús

    المساهمون: University/Department: Universitat de Barcelona. Facultat de Medicina

    Thesis Advisors: García del Muro Solans, Xavier, Martínez Tirado, Òscar

    المصدر: TDX (Tesis Doctorals en Xarxa)

    وصف الملف: application/pdf

  2. 2
  3. 3
    Academic Journal

    المصدر: Melero, Ignacio; de Miguel Luken, Maria; de Velasco, Guillermo; Garralda, Elena; Martín-Liberal, Juan; Joerger, Markus; Alonso, Guzman; Goebeler, Maria-Elisabeth; Schuler, Martin; König, David; Dummer, Reinhard; Reig, Maria; Rodriguez Ruiz, Maria-Esperanza; Calvo, Emiliano; Esteban-Villarrubia, Jorge; Oberoi, Arjun; Sabat, Paula; Soto-Castillo, Juan José; Koster, Kira-Lee; Saavedra, Omar; Sayehli, Cyrus; Gromke, Tanja; Läubli, Heinz; Ramelyte, Egle; Fortuny, Marta; Landa-Magdalena, Ana; Moreno, Irene; Torres-Jiménez, Javier; Hernando-Calvo, Alberto; Hess, Dagmar; et al (2024). Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours. Nature:Epub ahead of print.

    مصطلحات موضوعية: Dermatology Clinic, 610 Medicine & health

    وصف الملف: application/pdf

  4. 4
    Academic Journal

    المصدر: Lopez-Cerda , M , Lorenzo-Sanz , L , da Silva-Diz , V , Llop , S , Penin , R M , Bermejo , J O , de Goeij-de Haas , R , Piersma , S R , Pham , T V , Jimenez , C R , Martin-Liberal , J & Muñoz , P 2024 , ' IGF1R signaling induces epithelial-mesenchymal plasticity via ITGAV in cutaneous carcinoma ' , JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol. 43 , no. 1 , 211 . https://doi.org/10.1186/s13046-024-03119-3

  5. 5
  6. 6
  7. 7
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal

    المصدر: Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

    مصطلحات موضوعية: Immunoteràpia, Cèl·lules T, Immunotherapy, T cells

    وصف الملف: 24 p.; application/pdf

    Relation: Reproducció del document publicat a: https://doi.org/10.1186/s13046-022-02264-x; Journal of Experimental & Clinical Cancer Research, 2022, vol 41, num 1; https://doi.org/10.1186/s13046-022-02264-x; http://hdl.handle.net/2445/183764

  18. 18
    Academic Journal

    المساهمون: Institut Català de la Salut, Davis EJ Vanderbilt University Medical Center, Nashville, Tennessee, USA. Martin-Liberal J, Vieito M Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Kristeleit R Research Department of Oncology, University College London, London, UK. Cho DC Perlmutter Cancer Center, NYU Langone Health, NYU Grossman School of Medicine, New York, USA. Blagden SP Department of Oncology, University of Oxford, Oxford, UK. Berthold D Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal for ImmunoTherapy of Cancer;10(10); http://dx.doi.org/10.1136/jitc-2021-004235; Davis EJ, Martin-Liberal J, Kristeleit R, Cho DC, Blagden SP, Berthold D, et al. First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors. J Immunother Cancer. 2022 Oct;10(10):e004235.; https://hdl.handle.net/11351/8540; 000877526500002

  19. 19
    Academic Journal

    المساهمون: Institut Català de la Salut, Choudhury AD Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Higano CS Department of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. de Bono JS Drug Development Unit, The Institute of Cancer Research and Royal Marsden, London, United Kingdom. Cook N The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom. Rathkopf DE Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, New York. Wisinski KB Carbone Cancer Center, University of Wisconsin–Madison, Madison, Wisconsin. Martin-Liberal J Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Clinical Cancer Research;28(11); https://doi.org/10.1158/1078-0432.CCR-21-3087; Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, et al. A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2022 Jun 1;28(11):2257–69.; https://hdl.handle.net/11351/8076; 000809230200001

  20. 20
    Academic Journal